期刊
CURRENT OPINION IN IMMUNOLOGY
卷 53, 期 -, 页码 58-63出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2018.04.003
关键词
-
类别
资金
- Swedish Cancer Society [16 0585]
- Swedish Research Foundation [2015-02375_3]
- Wallenberg Scholar grant from the Knot and Alice Wallenberg foundation
- Swedish Research Council [2015-02375] Funding Source: Swedish Research Council
Lymphatic vessels are established by differentiation of lymphendothelial progenitors during embryogenesis. Lymphangiogenesis, the formation of new lymphatic vessels from pre-existing ones is rare in the healthy adult but takes place during pathological conditions such as inflammation, tissue repair and tumor growth. Conditions of dysfunctional lymphatics exist after surgical interventions or in certain genetic diseases. A key lymphangiogenic stimulator is vascular endothelial growth factor-C (VEGFC) acting on VEGF receptor-3 (VEGFR3) expressed on lymphendothelial cells. Other cytokines may act directly to regulate lymphangiogenesis positively or negatively, or indirectly by inducing expression of VEGFC. This review describes different known lymphangiogenic cytokines, their mechanism of action and role in lymphangiogenesis in health and disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据